DiNuzzo Private Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$31.4K Sell
1,102
-20
-2% -$532 ﹤0.01% 172
2026
Q2
$27K Buy
1,122
+4
+0.4% +$105 ﹤0.01% 182
2026
Q1
$31.4K Hold
1,118
– – ﹤0.01% 161
2025
Q4
$27.8K Buy
1,118
+27
+2% +$681 ﹤0.01% 166
2025
Q3
$27K Buy
1,091
+17
+2% +$420 ﹤0.01% 167
2025
Q2
$26K Buy
1,074
+6
+0.6% +$140 ﹤0.01% 168
2025
Q1
$27.1K Buy
1,068
+73
+7% +$1.91K ﹤0.01% 154
2024
Q4
$26.4K Sell
995
-321
-24% -$8.71K ﹤0.01% 158
2024
Q3
$38.1K Sell
1,316
-5
-0.4% -$146 ﹤0.01% 141
2024
Q2
$37K Buy
1,321
+34
+3% +$936 0.01% 109
2024
Q1
$35.7K Sell
1,287
-4
-0.3% -$111 ﹤0.01% 108
2023
Q4
$37.2K Buy
+1,291
New +$39K 0.01% 106

Other funds holding PFE

DiNuzzo Private Wealth's PFE Position: Q3 2026 in Review

DiNuzzo Private Wealth reduced its Pfizer (PFE) stake by 1.8% in Q3 2026, selling an estimated $532 and leaving 1,102 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #172.

DiNuzzo Private Wealth first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. The position peaked at $38.1K in Q3 2024. 1,083 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • DiNuzzo Private Wealth held 1,102 shares of Pfizer worth $31.4K as of Q3 2026.
  • DiNuzzo Private Wealth sold 20 Pfizer shares in Q3 2026, an estimated $532.
  • Pfizer made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q3 2026, its #172 holding.
  • DiNuzzo Private Wealth first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
  • DiNuzzo Private Wealth's Pfizer position peaked at $38.1K in Q3 2024.
  • 1,083 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.